Riociguat

Red

Brand Name(s):Adempas

Indication:Pulmonary Hypertension – Improvement of exercise capacity in adults with WHO Functional Class (FC) II-III chronic thromboembolic pulmonary hypertension that is inoperable or persistent or recurrent after surgical treatment, or WHO FC II-III pulmonary arterial hypertension.

Rationale:1, 2

Considered:Apr-14

Review Date:Aug-21

Comments:
Drug Safety Update
Riociguat (Adempas): not for use in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias
Aug 2016